CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 163 filers reported holding CLOVIS ONCOLOGY INC in Q3 2021. The put-call ratio across all filers is 1.12 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $19,000 | -44.1% | 16,075 | -15.4% | 0.00% | – |
Q2 2022 | $34,000 | -10.5% | 19,000 | +0.5% | 0.00% | – |
Q1 2022 | $38,000 | -20.8% | 18,912 | +6.4% | 0.00% | – |
Q4 2021 | $48,000 | -35.1% | 17,774 | +6.5% | 0.00% | – |
Q3 2021 | $74,000 | -16.9% | 16,696 | +9.0% | 0.00% | – |
Q2 2021 | $89,000 | -20.5% | 15,324 | -4.0% | 0.00% | – |
Q1 2021 | $112,000 | +67.2% | 15,964 | +14.8% | 0.00% | – |
Q4 2020 | $67,000 | -13.0% | 13,908 | +5.5% | 0.00% | – |
Q3 2020 | $77,000 | -12.5% | 13,180 | +1.2% | 0.00% | – |
Q2 2020 | $88,000 | -37.1% | 13,019 | -40.5% | 0.00% | – |
Q1 2020 | $140,000 | +300.0% | 21,884 | +146.6% | 0.00% | – |
Q3 2019 | $35,000 | +288.9% | 8,876 | +4596.3% | 0.00% | – |
Q2 2018 | $9,000 | -98.8% | 189 | -98.7% | 0.00% | -100.0% |
Q1 2018 | $772,000 | +5838.5% | 14,629 | +7640.2% | 0.00% | – |
Q4 2017 | $13,000 | -18.8% | 189 | 0.0% | 0.00% | – |
Q3 2017 | $16,000 | -11.1% | 189 | 0.0% | 0.00% | – |
Q2 2017 | $18,000 | -98.7% | 189 | -99.1% | 0.00% | -100.0% |
Q1 2017 | $1,362,000 | +16925.0% | 21,393 | +11463.8% | 0.00% | – |
Q4 2016 | $8,000 | +33.3% | 185 | +6.3% | 0.00% | – |
Q3 2016 | $6,000 | +200.0% | 174 | +8.1% | 0.00% | – |
Q2 2016 | $2,000 | -33.3% | 161 | +2.5% | 0.00% | – |
Q1 2016 | $3,000 | -40.0% | 157 | +9.0% | 0.00% | – |
Q4 2015 | $5,000 | -58.3% | 144 | +7.5% | 0.00% | – |
Q3 2015 | $12,000 | +9.1% | 134 | +10.7% | 0.00% | – |
Q2 2015 | $11,000 | – | 121 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 814,833 | $60,485,054,000 | 53.20% |
Palo Alto Investors LP | 2,121,857 | $157,505,000 | 7.79% |
NEA Management Company, LLC | 2,279,781 | $169,228,000 | 7.65% |
EcoR1 Capital, LLC | 243,048 | $18,041,000 | 6.01% |
Redmile Group, LLC | 900,879 | $66,872,000 | 6.00% |
Opaleye Management Inc. | 140,000 | $10,392,000 | 4.82% |
PFM Health Sciences, LP | 2,266,756 | $168,261,000 | 4.64% |
Partner Investment Management, L.P. | 40,798 | $3,028,000 | 4.56% |
CLIFTON PARK CAPITAL MANAGEMENT, LLC | 826,919 | $61,383,000 | 3.74% |
Opus Point Partners Management, LLC | 55,988 | $4,156,000 | 3.48% |